The latest Pharma Industry News & articles published
daily. Includes news on pharmaceutical companies, mergers and
acquisitions, drug development, export and import of drugs,
legislation, advertising and influence.
Taj Pharma offers accurate, readable and informative news reports
Corporate News and Press Release -
US approves Pegasys and Copegus as first hepatitis C treatment
for HIV patients more..
Pegasys approved in the European Union for the treatment of
chronic hepatitis B more..
Xeloda: positive opinion in EU for treatment of colon cancer
after surgery more..
Pegasys combination therapy approved for the treatment of
hepatitis C and HIV co-infection in Europe more..
Annual Media Conference more..
TAJ Pharmaceuticals in 2004: Net income doubled - further
significant improvement in operating profitability and
financial position more..
TAJ Pharmaceuticals to launch publicly accessible databases
for clinical trials more..
Pegasys receives positive opinion in the European Union for
the treatment of chronic hepatitis B more..
Innovative Taj Pharmaceuticals cancer medicine Avastin
approved in EU more..
Taj Pharma's AmpliChip CYP450 Test receives FDA clearance more..
Sale of Taj Consumer Health to Bayer completed more..
Growing Stronger, Growing
Taj GenericsA generic
drug (generic drugs, short: generics) is a drug which is
produced and distributed without patent protection. The
generic drug may still have a patent on the formulation
but not on the active ingredient
and Facilities : The manufacturing facilities are based in
Valsad (Gujarat) and Raigad (Raigarh, Maharashtra) and
operated by Taj Pharmaceuticals Ltd
Pharmaceuticals Ltd is keen to capitalize on new
opportunities emerging in the generics market. The company
is right now focusing on dermatology, respiratory and